UA86051C2 - Substituted quinoline compounds - Google Patents

Substituted quinoline compounds

Info

Publication number
UA86051C2
UA86051C2 UAA200608717A UAA200608717A UA86051C2 UA 86051 C2 UA86051 C2 UA 86051C2 UA A200608717 A UAA200608717 A UA A200608717A UA A200608717 A UAA200608717 A UA A200608717A UA 86051 C2 UA86051 C2 UA 86051C2
Authority
UA
Ukraine
Prior art keywords
compounds
substituted quinoline
quinoline compounds
compositions
mtp
Prior art date
Application number
UAA200608717A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Питер Бертинато
Мишель Андрэ Кутюрье
Эрнест Сеичи Хаманака
Маркус Дуглас Ивинг
мл. Робинсон Ральф Пелтон
Дерек Лоуренс Тиккнер
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of UA86051C2 publication Critical patent/UA86051C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

This invention relates to MTP/Apo В secretion inhibitors of Formula (I) wherein R-R, X, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.(I)
UAA200608717A 2004-02-04 2005-01-24 Substituted quinoline compounds UA86051C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54167804P 2004-02-04 2004-02-04

Publications (1)

Publication Number Publication Date
UA86051C2 true UA86051C2 (en) 2009-03-25

Family

ID=37722570

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200608717A UA86051C2 (en) 2004-02-04 2005-01-24 Substituted quinoline compounds

Country Status (5)

Country Link
CN (1) CN1914195A (en)
GT (1) GT200500016A (en)
TN (1) TNSN06247A1 (en)
UA (1) UA86051C2 (en)
ZA (1) ZA200605575B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314938B2 (en) 2003-11-05 2008-01-01 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
EP3797775A1 (en) 2007-10-19 2021-03-31 Novartis AG Compositions and methods for treatment of diabetic retinopathy
CN104844509A (en) * 2014-02-14 2015-08-19 河南工业大学 Mild-condition and metal-free method for preparing aminoquinoline derivatives

Also Published As

Publication number Publication date
ZA200605575B (en) 2008-01-30
TNSN06247A1 (en) 2007-12-03
GT200500016A (en) 2005-08-18
CN1914195A (en) 2007-02-14

Similar Documents

Publication Publication Date Title
GEP20084360B (en) Substituted quinoline compounds
UA83875C2 (en) Quinoline derivatives for use as mycobacterial inhibitors
MX2009006195A (en) 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use.
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
IL182218A0 (en) Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity
TNSN08373A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
NO20084652L (en) Deazapurins useful as inhibitors of januskinases
WO2006106326A8 (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
PT1902037E (en) 2,4-diamino-pyrimidines used as aurora inhibitors
MXPA05013224A (en) Pyridinyl carbamates as hormone-sensitive lipase inhibitors.
TN2009000128A1 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
SE0403006D0 (en) New compounds
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
MX2009003981A (en) Calcium receptor modulating agents.
NO20055563L (en) Means for the treatment of lower abdominal disorders
NO20073839L (en) Quinoline derivative, method of preparation and use thereof, and drug containing it
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
ATE419249T1 (en) INHIBITORS OF MITOTIC KINESIN
ES2333026T3 (en) DERIVED FROM CICLOHEXIL-1,4-DIAMINE SUBSTITUTED.
EA201170344A1 (en) AZAINDOL IAP INHIBITORS
ATE466841T1 (en) 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS
DE602005014632D1 (en) PYRROL-BZW. IMIDAZOLAMIDE FOR THE TREATMENT OF OBESITAS
GB0407025D0 (en) Novel compounds